The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment ...

Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and ...

Sydnie Mason laughs with her lab partner at the SNC GlaxoSmithKline Summer Immersion Experience in Biotech, a biotechnology ...

GSK announced today that Health Canada has approved Blenrep (belantamab mafodotin for injection) in combination with ...

Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and resurfacing even ...

Among patients with severe asthma receiving dupilumab for 12 months, 91% had a clinical response and 30% achieved clinical remission.

Leading National Hunt owner Brian Acheson, whose family race under the Robcour banner, has made a shock entry into the world ...

Get all latest & breaking news on Corona Remedies. Watch videos, top stories and articles on Corona Remedies at moneycontrol.com.

A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a ...

Just when the future looked bleak for GSK’s Blenrep comeback in the U.S., the FDA has blessed the company's multiple myeloma ...

GSK PLC GSK shares rose 1.78% to £13.72 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.42% to 9,061.49. GSK PLC ...

GSK said the U.S. Food and Drug Administration extended its review period for Blenrep combinations to treat patients with relapsed or refractory multiple myeloma.